This analysis revealed that the prognostic impact of differential INTS13 expression (high versus low) on cervical cancer survival was particularly prominent and statistically significant within the higher body weight subgroup (BMI > 25), where high INTS13 expression correlated with markedly reduced survival (Fig. 1L). The gene discussed is INTS13; the disease is cervical cancer.